Aerosolized liposomal Amphotericin B: A potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients&
PDF) Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial
Aerosolized liposomal Amphotericin B: A potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients - Kamalaporn - 2014 - Pediatric Pulmonology - Wiley Online Library
Aerosolization of Liposomal Amphotericin B (AmBisome®) Maintains Antifungal Drug Concentrations in Lungs for up to Five Days Po
Aerosolized amphotericin B as prophylaxis for invasive pulmonary aspergillosis: a meta-analysis
PDF) Comparison of Amphotericin B Lipid Complex (Abelcet) and Liposomal Amphotericin B (Ambisome) on Rat Kidney: a Morphological Evaluation
Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety - The Journal of Heart and Lung Transplantation
amphotericin b Clinical Pharmacology Drug Monograph
Aerosolization of Liposomal Amphotericin B (AmBisome®) Maintains Antifungal Drug Concentrations in Lungs for up to Five Days Po
Delivery strategies of amphotericin B for invasive fungal infections - ScienceDirect
Reduction toxicity of Amphotericin B through loading into a novel nanoformulation of anionic linear globular dendrimer for improve treatment of leishmania major | SpringerLink
Full article: Tissue pharmacokinetics and pharmacodynamics of AmBisome® (L-AmBis) in uninfected and infected animals and their effects on dosing regimens
AmBisome on Vimeo
Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions | SpringerLink
PDF) Aerosolized liposomal Amphotericin B: A potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients | R. Reithmeier - Academia.edu
Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis
Pharmaceutics | Free Full-Text | Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy | HTML
Ambisome <br> Antifungal Amphotericin B Liposome <br>50 mg / 20 mL Intravenous Injection <br>Vial 20
A Review on the Clinical Use of Inhaled Amphotericin B
PDF) Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant
Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung trans
liposomal amphotericin b injection 50mg, Prescription at best price in Solan
Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis | Critical Care | Full Text
Aerosolized amphotericin B as prophylaxis for invasive pulmonary aspergillosis: a meta-analysis - ScienceDirect
Amphotericin B induces epithelial voltage responses in people with cystic fibrosis - Journal of Cystic Fibrosis
Liposomal Amphotericin B Formulation Displaying Lipid-Modified Chitin-Binding Domains with Enhanced Antifungal Activity | Molecular Pharmaceutics
A review on the clinical use of inhaled amphotericin B - Document - Gale Academic OneFile
PDF) Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization | maha nasr - Academia.edu
